Methylnaltrexone Bromide
5 NDCs across 1 manufacturer|0 Generic,5 Brand
Methylnaltrexone Bromide is used to treat constipation, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 24, 2008, and the first generic was approved Aug 26, 2024. In 2024, Medicare Part D spent $135 million on Methylnaltrexone Bromide across 57,000 claims for 16,000 beneficiaries.
Methylnaltrexone Bromide is available as 5 NDCs from 1 manufacturer (0 generic, 5 brand), with NADAC prices from $271.21 to $409.77 per ML — a 51% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
0G / 5B
Manufacturers
1
competing in market
Price Spread
$271.21 – $409.77
per ML, 4 of 5 NDCs
7d Activity
avg +0.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Salix Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Opioid Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing METHYLNALTREXONE BROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RELISTOR 8 MG/0.4 ML SYRINGE | $409.7653 per ML | — |
RELISTOR 12 MG/0.6 ML SYRINGE | $272.6830 per ML | — |
RELISTOR 12 MG/0.6 ML VIAL | $271.5833 per ML | — |
RELISTOR 12 MG/0.6 ML SYRINGE | $271.2074 per ML | — |
RELISTOR 150 MG TABLET | $26.8914 per EA | — |
Frequently Asked Questions
What is Methylnaltrexone Bromide used to treat?
Methylnaltrexone Bromide is used to treat constipation, per the National Library of Medicine's MED-RT classification.
When did Methylnaltrexone Bromide become available as a generic?
FDA approved the first generic Methylnaltrexone Bromide (ANDA) on Aug 26, 2024.
How much does Medicare spend on Methylnaltrexone Bromide?
In 2024, Medicare Part D spent $135 million on Methylnaltrexone Bromide across 57,000 claims for 16,000 beneficiaries.
How many Methylnaltrexone Bromide products are on the market?
The Methylnaltrexone Bromide drug market contains 5 NDCs from 1 manufacturer — 0 generic and 5 brand products.
What is the price range for Methylnaltrexone Bromide?
NADAC reference prices for Methylnaltrexone Bromide range from $271.2074 to $409.7653 per ML — a 51% difference between cheapest and most expensive. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Methylnaltrexone Bromide?
1 manufacturer lists Methylnaltrexone Bromide in NADAC. Ranked by number of NDCs, the largest are Salix Pharmaceuticals Inc. (5).